RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) — (NASDAQ:RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter and fiscal year 2022 after the market close on Monday, March 6, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Related news for (RXST)
- RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
- RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
- RxSight Reports Q2 2024 Financial Results
- RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
- RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference